文献速递瓣膜外科

戊二醛处理自体心包行主动脉瓣新瓣叶成形术的中期结局

Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-02-15

该研究回顾性分析了2007年4月至2015年12月接受自体心包主动脉瓣新瓣叶成形术(AVNeo)的850例患者,随访最长118个月。术后主动脉瓣峰值压差从术前平均68.9±36.3 mm Hg降至术后1周19.5±10.3 mm Hg和术后8年15.2±6.3 mm Hg。免于死亡、再手术累积发生率和复发性中度及以上主动脉瓣反流累积发生率分别为85.9%、4.2%和7.3%。

要点

  • AVNeo术后1周主动脉瓣峰值压差平均19.5±10.3 mm Hg,术后8年平均15.2±6.3 mm Hg。
  • 最长随访118个月时,免于死亡、再手术累积发生率和复发性中度及以上主动脉瓣反流累积发生率分别为85.9%、4.2%和7.3%。
  • 15例需再手术,其中13例感染性心内膜炎、1例缝线断裂、1例瓣叶撕裂。

核心结论

  • 使用自体心包的AVNeo在850例各种主动脉瓣疾病患者中的中期结局令人满意。
  • 作者认为需要进一步的随机、多中心前瞻性研究来证实本研究结果。

研究设计与样本

  • 回顾性审查2007年4月至2015年12月接受AVNeo使用自体心包的850例患者的医疗记录。
  • 手术基于使用自体心包独立行三瓣叶置换,用原创 sizing device 测量交界间距离,用原创模板修剪心包瓣叶后缝合至瓣环。
  • 患者中主动脉瓣狭窄534例、主动脉瓣反流254例、主动脉瓣狭窄伴反流61例、感染性心内膜炎19例、既往主动脉瓣手术5例。
  • 三叶式主动脉瓣596例、二叶式224例、单叶式28例、四叶式2例;男性444例、女性406例;中位年龄71岁(范围13-90岁)。
  • 术前超声心动图显示主动脉瓣狭窄患者峰值压差平均68.9±36.3 mm Hg;手术瓣环直径20.9±3.3 mm。

主要发现

  • 无中转人工瓣膜置换。
  • 院内死亡16例。
  • 术后超声心动图显示峰值压差平均术后1周为19.5±10.3 mm Hg,术后8年为15.2±6.3 mm Hg。
  • 15例需再手术,其中感染性心内膜炎13例、缝线断裂1例、瓣叶撕裂1例。
  • 平均随访53.7±28.2个月,最长随访118个月;免于死亡、再手术累积发生率和复发性中度及以上主动脉瓣反流累积发生率分别为85.9%、4.2%和7.3%。

局限性

  • 原文结论指出需要进一步的随机、多中心前瞻性研究来证实本研究结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We had previously reported the short-term results of the aortic valve neocuspidization (AVNeo) procedure. We have now evaluated the midterm results with the longest follow-up of 118 months. METHODS: From April 2007 through December 2015, 850 patients were treated with AVNeo using autologous pericardium. Medical records of these patients were retrospectively reviewed. The procedure was on the basis of independent tricuspid replacement using autologous pericardium. The distances between the commissures were measured with an original sizing device, the pericardial cusp was trimmed using an original template, and then sutured to the annulus. RESULTS: There were 534 patients with aortic stenosis, 254 with aortic regurgitation, 61 with aortic stenoregurgitation, 19 with infective endocarditis, and 5 with a previous aortic valve procedure. Besides 596 patients with tricuspid aortic valve, 224 patients had bicuspid valve, 28 had unicuspid valve, and 2 had quadricuspid valve. There were 444 male and 406 female patients. The median age was 71 (range, 13-90) years old. Preoperative echocardiography revealed a peak pressure gradient average of 68.9 ± 36.3 mm Hg with aortic stenosis. Surgical annular diameter was 20.9 ± 3.3 mm. There was no conversion to a prosthetic valve replacement. There were 16 in-hospital mortalities. Postoperative echocardiography revealed a peak pressure gradient average of 19.5 ± 10.3 mm Hg 1 week after surgery and 15.2 ± 6.3 mm Hg 8 years after surgery. Fifteen patients needed reoperation (13 infective endocarditis, 1 break of thread, and 1 tear of cusp case). The mean follow-up period was 53.7 ± 28.2 months. Actuarial freedom from death, cumulative incidence of reoperation, and that of recurrent moderate aortic regurgitation or greater was 85.9%, 4.2%, and 7.3%, respectively, with the longest follow-up of 118 months. CONCLUSIONS: The midterm outcomes of AVNeo using autologous pericardium were satisfactory in 850 patients with various aortic valve diseases. However, further randomized, multicenter prospective studies are needed to confirm the results of the current study.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ozaki S, Kawase I, Yamashita H, et al. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2018. PMID: 29567131. doi:10.1016/j.jtcvs.2018.01.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。